Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL in Prediabetic Patients with Cystic Fibrosis

Por um escritor misterioso
Last updated 24 setembro 2024
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Inhalation of specific anti-Pseudomonas aeruginosa IgY antibodies transiently decreases P. aeruginosa colonization of the airway in mechanically ventilated piglets, Intensive Care Medicine Experimental
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
PDF) Review Article Diabetes mellitus in patients with cystic fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta‐analysis - Morselli‐Labate - 2009 - Journal of Gastroenterology and Hepatology - Wiley Online Library
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Frontiers Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Research articles Pediatric Research
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
SciELO - Brasil - Diabetes melito: uma importante co-morbidade da fibrose cística Diabetes melito: uma importante co-morbidade da fibrose cística
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Systems serology in cystic fibrosis: Anti-Pseudomonas IgG1 responses and reduced lung function - ScienceDirect
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
PDF) Cystic Fibrosis–Related Diabetes in Adolescents
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infections
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL in Prediabetic Patients with Cystic Fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL  in Prediabetic Patients with Cystic Fibrosis
Frontiers Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

© 2014-2024 vasevaults.com. All rights reserved.